Mammalian mitochondria are involved in all of the following processes except?
Which of the following statements regarding the electron transport chain is FALSE?
Which of the following enzymes of the TCA cycle is analogous to the Pyruvate dehydrogenase complex?
What is the P/O ratio observed in the aerobic oxidation of reduced cytochromes?
What is the primary source of readily available energy for most cells in the body?
Which component of the electron transport chain transfers four protons?
How many net ATP molecules are generated from one molecule of glucose entering the Krebs cycle?
Which enzymes use molecular oxygen as a hydrogen acceptor to produce water?
In the citric acid cycle (Krebs cycle), which enzyme catalyzes the rate-limiting step?
The PRIMARY mechanism of toxicity of which substance is NOT through Cytochrome C oxidase inhibition?
Explanation: **Explanation:** The correct answer is **D. Protein synthesis**. While mitochondria contain their own ribosomes (mitoribosomes) and synthesize a small number of proteins (13 essential subunits of the respiratory chain), the vast majority of mammalian protein synthesis occurs in the **cytosol** (via free ribosomes) or on the **Rough Endoplasmic Reticulum (RER)**. In the context of general metabolic pathways, protein synthesis is primarily considered a cytoplasmic/ER function. **Analysis of Options:** * **A. Fatty acid synthesis:** While the "de novo" synthesis of palmitate occurs in the cytosol, mitochondria are involved in **fatty acid elongation** (adding 2-carbon units to existing chains). Furthermore, the precursor for synthesis, Acetyl-CoA, is generated within the mitochondria and must be transported out via the Citrate-Malate shuttle. * **B. DNA synthesis:** Mitochondria possess their own circular, double-stranded DNA (**mtDNA**). They have the necessary machinery (DNA polymerase gamma) for independent **replication**, making DNA synthesis a definitive mitochondrial process. * **C. Fatty acid oxidation (beta-oxidation):** This is a hallmark mitochondrial process. Long-chain fatty acids are transported into the mitochondrial matrix via the **Carnitine shuttle** to undergo beta-oxidation, producing Acetyl-CoA for the TCA cycle. **High-Yield Clinical Pearls for NEET-PG:** * **Mitochondrial DNA (mtDNA):** It is inherited exclusively from the **mother** (Maternal inheritance). * **Dual Site Pathways:** Remember the mnemonic **"HUG"** for pathways occurring in both mitochondria and cytosol: **H**eme synthesis, **U**rea cycle, and **G**luconeogenesis. * **Mitochondrial Ribosomes:** They are **55S** (35S and 25S subunits), which is different from the cytoplasmic 80S ribosomes, making them susceptible to certain antibiotics like chloramphenicol.
Explanation: ### Explanation **1. Why Option B is the Correct (False) Statement:** Atractyloside does not inhibit "H+/ADP synthesis." Instead, it is a specific inhibitor of the **Adenine Nucleotide Translocase (ANT)**, a transporter located in the inner mitochondrial membrane. ANT is responsible for the 1:1 exchange of mitochondrial ATP for cytosolic ADP. By blocking this exchange, the supply of ADP inside the matrix is depleted, which secondarily halts ATP synthesis. It does not directly inhibit H+ movement or the synthesis process itself. **2. Analysis of Other Options:** * **Option A (Cyanide):** This is a **respiratory chain inhibitor**. It binds to the ferric iron ($Fe^{3+}$) in **Cytochrome c oxidase (Complex IV)**, blocking the reduction of oxygen to water. Because electron transport is coupled to phosphorylation, ATP synthesis also stops, but the primary site of inhibition is the transport chain. * **Option C (Oligomycin):** This is a direct **ATP synthase inhibitor**. It binds to the $F_o$ subunit of Complex V, physically blocking the proton ($H^+$) channel. This prevents protons from flowing back into the matrix, thereby stopping ATP production. * **Option D (Aspirin):** High doses of salicylates act as **uncouplers**. They dissipate the proton gradient by carrying $H^+$ across the inner membrane. This allows electron transport to continue (often at an accelerated rate) but prevents ATP synthesis, leading to energy being released as heat. **3. High-Yield Clinical Pearls for NEET-PG:** * **Uncouplers:** Cause a decrease in ATP synthesis, an increase in $O_2$ consumption, and an increase in body temperature (e.g., 2,4-DNP, Thermogenin, High-dose Aspirin). * **Complex IV Inhibitors:** Cyanide, Carbon Monoxide (CO), Azide, and $H_2S$. * **Complex I Inhibitor:** Rotenone, Amobarbital (Amytal), and Piericidin A. * **Complex III Inhibitor:** Antimycin A. * **Bongkrekic Acid:** Another inhibitor of Adenine Nucleotide Translocase (similar to Atractyloside).
Explanation: **Explanation:** The **Alpha-ketoglutarate dehydrogenase (α-KGDH) complex** is considered analogous to the **Pyruvate dehydrogenase (PDH) complex** because they share an identical reaction mechanism, structural organization, and co-factor requirements. **Why α-KGDH is the correct answer:** Both PDH and α-KGDH are multi-enzyme complexes that catalyze **oxidative decarboxylation**. They both require the same five essential co-factors (mnemonic: **T**ender **L**oving **C**are **F**or **N**oah): 1. **T**hiamine pyrophosphate (TPP/B1) 2. **L**ipoic acid 3. **C**oenzyme A (CoA) 4. **F**AD (B2) 5. **N**AD+ (B3) Structurally, both consist of three subunits (E1, E2, and E3). Notably, the **E3 subunit (Dihydrolipoyl dehydrogenase)** is genetically identical in both enzyme complexes. **Analysis of Incorrect Options:** * **Isocitrate dehydrogenase:** While it performs oxidative decarboxylation, it is a monomeric enzyme that requires only NAD+ (or NADP+) and $Mg^{2+}$/$Mn^{2+}$, not the five-factor complex. It is the rate-limiting step of the TCA cycle. * **Malate dehydrogenase:** Catalyzes the simple oxidation of malate to oxaloacetate using NAD+; no decarboxylation occurs. * **Succinate dehydrogenase:** Unique because it is the only TCA enzyme embedded in the inner mitochondrial membrane (Complex II of ETC) and uses FAD as an electron acceptor. **High-Yield Clinical Pearls for NEET-PG:** * **Arsenite Poisoning:** Arsenite inhibits both PDH and α-KGDH by binding to the -SH groups of **Lipoic acid**, leading to lactic acidosis and neurological symptoms. * **Thiamine Deficiency:** In B1 deficiency (Beriberi/Wernicke-Korsakoff), both enzymes lose activity, severely impairing glucose oxidation in the brain. * **Product Inhibition:** Both complexes are inhibited by their immediate products (NADH and Acetyl-CoA/Succinyl-CoA).
Explanation: **Explanation:** The **P/O ratio** (Phosphate/Oxygen ratio) refers to the number of ATP molecules synthesized per atom of oxygen reduced during the Electron Transport Chain (ETC). **Why Option B is Correct:** The aerobic oxidation of reduced cytochromes involves the transfer of electrons through the respiratory chain starting from **NADH**. When NADH enters the ETC at Complex I, it triggers the pumping of protons at three specific sites: 1. **Complex I** (NADH dehydrogenase) 2. **Complex III** (Cytochrome bc1 complex) 3. **Complex IV** (Cytochrome c oxidase) According to the classical (Malher) chemical coupling hypothesis often tested in NEET-PG, each of these three sites provides enough energy to phosphorylate one ADP to ATP. Therefore, for every NADH molecule oxidized, **3 ATPs** are produced, resulting in a P/O ratio of 3. **Why Other Options are Incorrect:** * **Option A (4):** There is no substrate in the human respiratory chain that yields 4 ATPs per oxygen atom reduced. * **Option C (2):** This is the P/O ratio for **FADH₂**. FADH₂ enters the ETC at Complex II, bypassing the first phosphorylation site (Complex I), thus generating only 2 ATPs. * **Option D (1):** This ratio is not characteristic of standard aerobic oxidation of NADH or FADH₂. **High-Yield Clinical Pearls for NEET-PG:** * **Modern Values:** While traditional exams use 3 for NADH and 2 for FADH₂, modern "Chemiosmotic" values are **2.5** and **1.5** respectively. Always prioritize traditional values (3 and 2) unless specified. * **Cyanide/CO Poisoning:** These inhibit Complex IV (Cytochrome oxidase), completely halting the P/O ratio as oxygen cannot be reduced. * **Uncouplers (e.g., 2,4-DNP):** These decrease the P/O ratio by allowing protons to leak back into the matrix without passing through ATP synthase, dissipating energy as heat.
Explanation: **Explanation:** The correct answer is **Glycogen**. **Why Glycogen is Correct:** Glycogen is a highly branched polymer of glucose that serves as the primary storage form of carbohydrates in animals. It is considered the "readily available" energy source because it can be rapidly mobilized through **glycogenolysis**. Unlike fats, glycogen can be broken down into glucose-6-phosphate, which enters glycolysis to produce ATP even in **anaerobic conditions**. This rapid mobilization is essential for maintaining blood glucose levels (via the liver) and providing immediate fuel for muscle contraction. **Why Other Options are Incorrect:** * **A. Fat (Triacylglycerols):** While fats provide the highest energy yield (9 kcal/g) and represent the body's largest energy reserve, they are mobilized slowly. They require oxygen for oxidation (aerobic only) and cannot be used as a rapid source of energy during high-intensity bursts. * **C. Lactate:** Lactate is a metabolic byproduct of anaerobic glycolysis. While it can be converted back to glucose in the liver via the **Cori Cycle**, it is a substrate for gluconeogenesis rather than a primary storage form of energy. * **D. Ketones:** Ketone bodies (e.g., acetoacetate, β-hydroxybutyrate) are alternative fuels produced during starvation or prolonged fasting. They are not the "primary" or "readily available" source under normal physiological conditions. **High-Yield NEET-PG Pearls:** * **Storage Sites:** The liver has the highest *concentration* of glycogen, but skeletal muscle contains the largest *total amount* due to its greater mass. * **Key Enzyme:** **Glycogen phosphorylase** is the rate-limiting enzyme of glycogenolysis, activated by glucagon and epinephrine. * **Muscle vs. Liver:** Muscle glycogen lacks **Glucose-6-phosphatase**; therefore, it cannot contribute to blood glucose and is used exclusively for local muscle contraction.
Explanation: **Explanation:** The Electron Transport Chain (ETC) is a series of protein complexes located in the inner mitochondrial membrane that couples electron transfer with proton pumping to create a gradient for ATP synthesis. **Why Complex I is correct:** **NADH-ubiquinone oxidoreductase (Complex I)** is the largest complex in the ETC. It accepts electrons from NADH and transfers them to Coenzyme Q (Ubiquinone). This exergonic transfer provides sufficient energy to pump exactly **four protons ($4H^+$)** from the mitochondrial matrix into the intermembrane space. This contributes significantly to the proton motive force. **Analysis of Incorrect Options:** * **Complex III (Ubiquinone-cytochrome c oxidoreductase):** While it also pumps protons, it transfers **four protons** per pair of electrons via the Q-cycle. However, in many standard medical texts and competitive exams, Complex I and III are both noted for 4 protons, but Complex I is the classic answer for the primary entry point of NADH-linked electrons. * **Complex IV (Cytochrome c oxidase):** This complex transfers electrons from Cytochrome c to Oxygen. It pumps only **two protons ($2H^+$)** into the intermembrane space for every pair of electrons, as some energy is consumed in the reduction of $O_2$ to $H_2O$. * **Isocitrate Dehydrogenase:** This is an enzyme of the TCA cycle, not a component of the ETC. It generates NADH but does not directly pump protons across the membrane. **High-Yield Clinical Pearls for NEET-PG:** * **Complex II (Succinate Dehydrogenase):** It is the only complex that **does not pump any protons**, which is why $FADH_2$ yields less ATP (1.5) than NADH (2.5). * **Inhibitors:** Rotenone inhibits Complex I; Antimycin A inhibits Complex III; Cyanide, CO, and Azide inhibit Complex IV. * **Leber’s Hereditary Optic Neuropathy (LHON):** Often caused by mutations in mitochondrial DNA encoding subunits of **Complex I**.
Explanation: **Explanation:** The question asks for the net ATP generated from one molecule of glucose specifically within the **Krebs cycle (Citric Acid Cycle)**. One molecule of glucose undergoes glycolysis to produce **two molecules of Acetyl-CoA**. Each Acetyl-CoA molecule entering the Krebs cycle undergoes one complete turn, yielding: * **3 NADH** (3 × 2.5 = 7.5 ATP) * **1 FADH₂** (1 × 1.5 = 1.5 ATP) * **1 GTP/ATP** (Substrate-level phosphorylation) * **Total per Acetyl-CoA:** 10 ATP (Modern yield) or 12 ATP (Old yield). Since one glucose produces two Acetyl-CoA, the total yield is **2 × 12 = 24 ATP**. **Analysis of Options:** * **Option A (12):** This is the ATP yield for only **one turn** of the Krebs cycle (one Acetyl-CoA). * **Option C (15):** This represents the ATP yield from one molecule of **Pyruvate** (12 from Krebs + 3 from Pyruvate Dehydrogenase complex). * **Option D (30):** This is the total net ATP yield of **complete glucose oxidation** (Glycolysis + Link Reaction + Krebs) using the Malate-Aspartate shuttle. **High-Yield NEET-PG Pearls:** 1. **Rate-limiting enzyme:** Isocitrate Dehydrogenase. 2. **Substrate-level phosphorylation:** Occurs at the step converting Succinyl-CoA to Succinate (catalyzed by Succinate thiokinase). 3. **Only membrane-bound enzyme:** Succinate Dehydrogenase (also part of Complex II of ETC). 4. **Inhibitors:** Fluoroacetate (inhibits Aconitase) and Arsenite (inhibits α-Ketoglutarate Dehydrogenase). 5. **ATP Yield Note:** While modern biochemistry (Lehninger) uses 2.5/1.5 ratios (total 20 ATP), NEET-PG traditionally follows the 3/2 ratio, making **24 ATP** the standard correct answer.
Explanation: ***Cytochrome c oxidase*** - This enzyme (Complex IV of the ETC) is responsible for the final step of cellular respiration, where it accepts electrons from **Cytochrome c**. - It catalyzes the four-electron reduction of molecular oxygen (**O₂**) to two molecules of **water** (**H₂O**), utilizing O₂ as the terminal hydrogen/electron acceptor. *Catalase* - Catalase breaks down **hydrogen peroxide** (**H₂O₂**) into water and molecular oxygen, acting as a peroxidase and protecting cells from reactive oxygen species. - It facilitates the breakdown of an existing toxic product and does not use O₂ as a hydrogen acceptor in a reduction reaction. *Superoxide dismutase* - This enzyme converts the hazardous **superoxide radical** (**O₂⁻**) into molecular oxygen and hydrogen peroxide. - It is critical for antioxidant defense but is involved in dismutation reactions, not in using O₂ as the final acceptor to form water. *Pyruvate dehydrogenase* - The pyruvate dehydrogenase complex links glycolysis to the Krebs cycle by converting **pyruvate** to **acetyl-CoA** (oxidative decarboxylation). - Its electron acceptors are **NAD⁺** and **lipoic acid** (which accept hydrogens/electrons to form NADH and reduced lipoic acid), not molecular oxygen.
Explanation: ***Isocitrate dehydrogenase*** - This enzyme catalyzes the conversion of **isocitrate to $\alpha$-ketoglutarate**, generating the first molecule of **NADH** and $CO_2$. - It is the primary **rate-limiting step** because its activity is tightly controlled allosterically, being inhibited by high levels of **ATP** and **NADH**, and activated by **ADP** and $Ca^{2+}$. *Citrate synthase* - This enzyme catalyzes the first reaction: the condensation of **acetyl-CoA** and **oxaloacetate** to form citrate. - While highly regulated by substrate availability, it is considered a secondary control point, as its control strength is usually lower than that of isocitrate dehydrogenase. *Alpha-ketoglutarate dehydrogenase* - This enzyme is the site of the second decarboxylation step, yielding another **NADH** and $CO_2$. - It is strongly inhibited by its products, **succinyl CoA** and **NADH**, but this regulation typically follows or supports the main control exerted by isocitrate dehydrogenase. *Succinate dehydrogenase* - This enzyme catalyzes the oxidation of succinate to fumarate, generating **$FADH_2$**, and is unique as it is part of the **electron transport chain (Complex II)**. - It is not considered a major rate-limiting control point for the overall flux of the citric acid cycle.
Explanation: ***Carbon monoxide (CO)*** - **Primary mechanism of toxicity** is through binding to hemoglobin forming **carboxyhemoglobin**, preventing oxygen transport - While CO can bind to **cytochrome oxidase**, its **dominant clinical effect** occurs at the oxygen delivery level, not cellular respiration *Hydrogen sulfide (H₂S)* - **Direct inhibitor** of cytochrome C oxidase by binding to the **heme iron center** - Functions similarly to cyanide, causing **histotoxic hypoxia** by blocking cellular oxygen utilization *Nitric oxide (NO)* - **Potent reversible inhibitor** of cytochrome C oxidase competing with oxygen at the active site - Physiological regulator of **cellular respiration** and important in hypoxia signaling pathways *Cyanide (CN⁻)* - **Classic inhibitor** of cytochrome C oxidase, binding with high affinity to the **oxidized cytochrome a₃** - Causes rapid **metabolic failure** by completely blocking the electron transport chain at Complex IV
Bioenergetics and Thermodynamics
Practice Questions
ATP as Energy Currency
Practice Questions
Tricarboxylic Acid Cycle
Practice Questions
Electron Transport Chain
Practice Questions
Oxidative Phosphorylation
Practice Questions
Mitochondrial Diseases
Practice Questions
Uncouplers and Inhibitors of Oxidative Phosphorylation
Practice Questions
Shuttle Systems: Malate-Aspartate and Glycerol-Phosphate
Practice Questions
Energy Yield from Nutrients
Practice Questions
Metabolic Rate and Basal Metabolism
Practice Questions
Brown Adipose Tissue and Thermogenesis
Practice Questions
Oxygen Toxicity and Free Radicals
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free